| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.383 | 0 | - | 8.381 | 9.799 | 9.214 | 13.544 | 4.477 | 10.330 | 11.966 |
| Total Income - EUR | 12.383 | 0 | - | 8.381 | 9.799 | 9.215 | 13.544 | 4.477 | 10.330 | 11.966 |
| Total Expenses - EUR | 3.613 | 0 | - | 0 | 368 | 5.384 | 4.304 | 3.175 | 8.102 | 6.902 |
| Gross Profit/Loss - EUR | 8.770 | 0 | - | 8.381 | 9.431 | 3.831 | 9.239 | 1.302 | 2.228 | 5.063 |
| Net Profit/Loss - EUR | 8.770 | 0 | - | 8.129 | 9.071 | 3.571 | 8.871 | 1.170 | 1.871 | 4.334 |
| Employees | 3 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Elvira Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 124 | 123 | - | 119 | 87 | 38 | 0 | 0 | 0 | 0 |
| Current Assets | 16.078 | 15.914 | - | 24.201 | 33.354 | 36.376 | 44.211 | 45.538 | 47.628 | 52.425 |
| Inventories | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 801 | 793 | - | 645 | 16.121 | 8.373 | 9.992 | 7.496 | 9.449 | 9.093 |
| Cash | 15.277 | 15.121 | - | 23.557 | 17.233 | 28.003 | 34.219 | 38.042 | 38.179 | 43.332 |
| Shareholders Funds | 15.940 | 15.778 | - | 24.251 | 32.852 | 35.800 | 43.877 | 45.184 | 46.918 | 50.990 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 262 | 259 | - | 69 | 589 | 614 | 334 | 354 | 710 | 1.435 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Elvira Med Srl